Report Detail

Pharma & Healthcare Global Graves Disease Treatment Market Research Report 2022

  • RnM4454452
  • |
  • 16 June, 2022
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
Industry Insights

Due to the COVID-19 pandemic, the global Graves Disease Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Graves Disease Treatment market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Graves Disease Treatment landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Anti-Thyroid Medication accounting for % of the Graves Disease Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals Pharmacies segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Graves Disease Treatment include Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc and Novartis AG, etc. In terms of revenue, the global 3 largest players have a % market share of Graves Disease Treatment in 2021.

This report focuses on Graves Disease Treatment volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Graves Disease Treatment market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe and China, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Graves Disease Treatment market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Anti-Thyroid Medication

Radioactive Iodine Therapy

Segment by Application

Hospitals Pharmacies

Retail Pharmacies

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Abbott

GlaxoSmithKline plc

Merck & Co

Pfizer, Inc

RLC LABS

AbbVie, Inc

Mylan N.V

Allergan, plc

Novartis AG

Apitope

Amgen INC.

Sun Pharmaceuticals Industries LTD

Immunovant Inc

Frequently Asked Questions

Which product segment grabbed the largest share in the Graves Disease Treatment market?

How is the competitive scenario of the Graves Disease Treatment market?

Which are the key factors aiding the Graves Disease Treatment market growth?

Which are the prominent players in the Graves Disease Treatment market?

Which region holds the maximum share in the Graves Disease Treatment market?

What will be the CAGR of the Graves Disease Treatment market during the forecast period?

Which application segment emerged as the leading segment in the Graves Disease Treatment market?

What key trends are likely to emerge in the Graves Disease Treatment market in the coming years?

What will be the Graves Disease Treatment market size by 2028?

Which company held the largest share in the Graves Disease Treatment market?


1 Graves Disease Treatment Market Overview

  • 1.1 Product Overview and Scope of Graves Disease Treatment
  • 1.2 Graves Disease Treatment Segment by Type
  • 1.2.1 Global Graves Disease Treatment Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Anti-Thyroid Medication
  • 1.2.3 Radioactive Iodine Therapy
  • 1.3 Graves Disease Treatment Segment by Application
  • 1.3.1 Global Graves Disease Treatment Sales Comparison by Application: (2022-2028)
  • 1.3.2 Hospitals Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.4 Global Graves Disease Treatment Market Size Estimates and Forecasts
  • 1.4.1 Global Graves Disease Treatment Revenue 2017-2028
  • 1.4.2 Global Graves Disease Treatment Sales 2017-2028
  • 1.4.3 Graves Disease Treatment Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Graves Disease Treatment Market Competition by Manufacturers

    • 2.1 Global Graves Disease Treatment Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Graves Disease Treatment Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Graves Disease Treatment Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Graves Disease Treatment Manufacturing Sites, Area Served, Product Type
    • 2.5 Graves Disease Treatment Market Competitive Situation and Trends
    • 2.5.1 Graves Disease Treatment Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Graves Disease Treatment Players Market Share by Revenue
  • 2.5.3 Global Graves Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Graves Disease Treatment Retrospective Market Scenario by Region

    • 3.1 Global Graves Disease Treatment Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Graves Disease Treatment Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Graves Disease Treatment Market Facts & Figures by Country
    • 3.3.1 North America Graves Disease Treatment Sales by Country
  • 3.3.2 North America Graves Disease Treatment Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Graves Disease Treatment Market Facts & Figures by Country
  • 3.4.1 Europe Graves Disease Treatment Sales by Country
  • 3.4.2 Europe Graves Disease Treatment Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Graves Disease Treatment Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Graves Disease Treatment Sales by Region
  • 3.5.2 Asia Pacific Graves Disease Treatment Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Graves Disease Treatment Market Facts & Figures by Country
  • 3.6.1 Latin America Graves Disease Treatment Sales by Country
  • 3.6.2 Latin America Graves Disease Treatment Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.7 Middle East and Africa Graves Disease Treatment Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Graves Disease Treatment Sales by Country
  • 3.7.2 Middle East and Africa Graves Disease Treatment Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Graves Disease Treatment Historic Market Analysis by Type

    • 4.1 Global Graves Disease Treatment Sales Market Share by Type (2017-2022)
    • 4.2 Global Graves Disease Treatment Revenue Market Share by Type (2017-2022)
    • 4.3 Global Graves Disease Treatment Price by Type (2017-2022)

    5 Global Graves Disease Treatment Historic Market Analysis by Application

    • 5.1 Global Graves Disease Treatment Sales Market Share by Application (2017-2022)
    • 5.2 Global Graves Disease Treatment Revenue Market Share by Application (2017-2022)
    • 5.3 Global Graves Disease Treatment Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Abbott
    • 6.1.1 Abbott Corporation Information
  • 6.1.2 Abbott Description and Business Overview
  • 6.1.3 Abbott Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Abbott Graves Disease Treatment Product Portfolio
  • 6.1.5 Abbott Recent Developments/Updates
  • 6.2 GlaxoSmithKline plc
  • 6.2.1 GlaxoSmithKline plc Corporation Information
  • 6.2.2 GlaxoSmithKline plc Description and Business Overview
  • 6.2.3 GlaxoSmithKline plc Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 GlaxoSmithKline plc Graves Disease Treatment Product Portfolio
  • 6.2.5 GlaxoSmithKline plc Recent Developments/Updates
  • 6.3 Merck & Co
  • 6.3.1 Merck & Co Corporation Information
  • 6.3.2 Merck & Co Description and Business Overview
  • 6.3.3 Merck & Co Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Merck & Co Graves Disease Treatment Product Portfolio
  • 6.3.5 Merck & Co Recent Developments/Updates
  • 6.4 Pfizer, Inc
  • 6.4.1 Pfizer, Inc Corporation Information
  • 6.4.2 Pfizer, Inc Description and Business Overview
  • 6.4.3 Pfizer, Inc Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Pfizer, Inc Graves Disease Treatment Product Portfolio
  • 6.4.5 Pfizer, Inc Recent Developments/Updates
  • 6.5 RLC LABS
  • 6.5.1 RLC LABS Corporation Information
  • 6.5.2 RLC LABS Description and Business Overview
  • 6.5.3 RLC LABS Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 RLC LABS Graves Disease Treatment Product Portfolio
  • 6.5.5 RLC LABS Recent Developments/Updates
  • 6.6 AbbVie, Inc
  • 6.6.1 AbbVie, Inc Corporation Information
  • 6.6.2 AbbVie, Inc Description and Business Overview
  • 6.6.3 AbbVie, Inc Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 AbbVie, Inc Graves Disease Treatment Product Portfolio
  • 6.6.5 AbbVie, Inc Recent Developments/Updates
  • 6.7 Mylan N.V
  • 6.6.1 Mylan N.V Corporation Information
  • 6.6.2 Mylan N.V Description and Business Overview
  • 6.6.3 Mylan N.V Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Mylan N.V Graves Disease Treatment Product Portfolio
  • 6.7.5 Mylan N.V Recent Developments/Updates
  • 6.8 Allergan, plc
  • 6.8.1 Allergan, plc Corporation Information
  • 6.8.2 Allergan, plc Description and Business Overview
  • 6.8.3 Allergan, plc Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Allergan, plc Graves Disease Treatment Product Portfolio
  • 6.8.5 Allergan, plc Recent Developments/Updates
  • 6.9 Novartis AG
  • 6.9.1 Novartis AG Corporation Information
  • 6.9.2 Novartis AG Description and Business Overview
  • 6.9.3 Novartis AG Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 Novartis AG Graves Disease Treatment Product Portfolio
  • 6.9.5 Novartis AG Recent Developments/Updates
  • 6.10 Apitope
  • 6.10.1 Apitope Corporation Information
  • 6.10.2 Apitope Description and Business Overview
  • 6.10.3 Apitope Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 Apitope Graves Disease Treatment Product Portfolio
  • 6.10.5 Apitope Recent Developments/Updates
  • 6.11 Amgen INC.
  • 6.11.1 Amgen INC. Corporation Information
  • 6.11.2 Amgen INC. Graves Disease Treatment Description and Business Overview
  • 6.11.3 Amgen INC. Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 Amgen INC. Graves Disease Treatment Product Portfolio
  • 6.11.5 Amgen INC. Recent Developments/Updates
  • 6.12 Sun Pharmaceuticals Industries LTD
  • 6.12.1 Sun Pharmaceuticals Industries LTD Corporation Information
  • 6.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Description and Business Overview
  • 6.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolio
  • 6.12.5 Sun Pharmaceuticals Industries LTD Recent Developments/Updates
  • 6.13 Immunovant Inc
  • 6.13.1 Immunovant Inc Corporation Information
  • 6.13.2 Immunovant Inc Graves Disease Treatment Description and Business Overview
  • 6.13.3 Immunovant Inc Graves Disease Treatment Sales, Revenue and Gross Margin (2017-2022)
  • 6.13.4 Immunovant Inc Graves Disease Treatment Product Portfolio
  • 6.13.5 Immunovant Inc Recent Developments/Updates
  • 7 Graves Disease Treatment Manufacturing Cost Analysis

    • 7.1 Graves Disease Treatment Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Graves Disease Treatment
  • 7.4 Graves Disease Treatment Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Graves Disease Treatment Distributors List
    • 8.3 Graves Disease Treatment Customers

    9 Graves Disease Treatment Market Dynamics

    • 9.1 Graves Disease Treatment Industry Trends
    • 9.2 Graves Disease Treatment Market Drivers
    • 9.3 Graves Disease Treatment Market Challenges
    • 9.4 Graves Disease Treatment Market Restraints

    10 Global Market Forecast

    • 10.1 Graves Disease Treatment Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Graves Disease Treatment by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Graves Disease Treatment by Type (2023-2028)
  • 10.2 Graves Disease Treatment Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Graves Disease Treatment by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Graves Disease Treatment by Application (2023-2028)
  • 10.3 Graves Disease Treatment Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Graves Disease Treatment by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Graves Disease Treatment by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on Graves Disease Treatment. Industry analysis & Market Report on Graves Disease Treatment is a syndicated market report, published as Global Graves Disease Treatment Market Research Report 2022. It is complete Research Study and Industry Analysis of Graves Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,401.20
      4,802.40
      2,781.10
      5,562.20
      392,428.00
      784,856.00
      229,042.00
      458,084.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report